MDXG 9.06 (-1.95%)
US6024961012Medical Devices & InstrumentsMedical Devices

MiMedx Group (MDXG) Stock Highlights

9.06 | -1.95%
2024-11-21 03:44:03
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedxs key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Statistics

Range Today
8.55 9.26
Volume Today 963.8K
Range 1 Year
5.47 9.49
Volume 1 Year 187.02M
Range 3 Year
2.43 9.49
Volume 3 Year 487.86M
Range 10 Year
0.95 18.25
Volume 10 Year 2.77B

Highlights

Market Capitalization 1.11B (small)
Floating Shares 116.67M
Current Price 9.06
Price To Earnings 12.83
Price To Revenue 3.02
Price To Book 6.11
Earnings Per Share 0.58
Payout Ratio 0%

Performance

Latest -1.95%
1 Month +56.75%
3 Months +39.17%
6 Months +16.6%
1 Year +28.51%
3 Years +17.05%
5 Years +53.56%
10 Years -13.71%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.